SV2A and Alzheimer disease: For example, positron emission studies using the SV2A radiotracer 11C-UCB-J and 18F-UCB-H have shown that AD patients had significantly less SV2A binding in the hippocampus compared to non-AD subjects (Chen et al., 2018; Bastin et al., 2020).